Funding Details
- Awarder
- Inbox
- Date Award
- May 17, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Traction
- The acquisition of TargImmune Therapeutics is expected to significantly enhance iOncologi's product offerings and market position.
- Company Description
- iOncologi is a biotechnology company focused on developing innovative therapies for cancer treatment. The acquisition of TargImmune Therapeutics enhances its capabilities in immunotherapy.
- Market
- Pharmaceuticals
- Location
-
United States
Links